Le Lézard
Classified in: Health, Science and technology
Subject: PDT

PeploBio and IncellDX Partner to Launch the First Long COVID Test in the UK and EU


GUILDFORD, England and HAYWARD, Calif., April 17, 2024 /PRNewswire/ -- PeploBio and IncellDX are launching the first laboratory developed test in the UK and EU to help diagnose Long COVID, providing doctors with accurate insights into personalised treatment approaches using the incellKINE Long Hauler Index technology.

Long COVID affects more than 65 million worldwide. The typical symptoms of Long COVID, ranging from fatigue, brain fog, shortness of breath, insomnia, to a spectrum of cardiovascular issues, are not exclusive to any single condition. This technological breakthrough aims to provide physicians with a definitive tool to differentiate Long COVID from other diseases sharing similar symptoms such as Lyme and ME-CFS.  

"Our collaboration with PeploBio marks a pivotal moment in the battle against Long COVID. The incellKINE Long Hauler Index technology enables us to identify a distinctive immunologic profile unique to Long COVID patients, providing a crucial first step for personalised treatment strategies," said Bruce Patterson, M.D., Founder and CEO at IncellDX. 

Dr. Nico Lambri, Managing Director at PeploBio said, "Our mission at PeploBio is to drive innovation in diagnostics, and our partnership with IncellDX underscores our commitment to advancing healthcare solutions. The introduction of this test fills a critical gap, empowering healthcare professionals with the tools needed to address the challenges posed by Long COVID." 

About PeploBio 

PeploBio is an ISO 15189 accredited clinical laboratory, committed to elevating precision medicine and bringing innovative diagnostic solutions to improve patient outcomes. 

About IncellDX 

IncellDx is a precision medicine company advancing novel diagnostics and prognostics to better understand and treat infectious disease and cancer. The company's innovative technology platform enables simultaneous cell classification and single cell analysis of proteomic and genomic biomarkers. 

For media enquiries, please contact: 

PeploBio:

IncellDX: 

Jack Purvis  

Julie Ferguson 

[email protected]

JFPRMEDIAGROUP 

+44 (0)1483 685 190

[email protected]


(312) 385-0098

SOURCE PeploBio


These press releases may also interest you

at 05:15
Guidehouse Insights Explores How Technology Advances are Changing the Role of Tires in Fleet Operations
A new report from Guidehouse Insights discusses how technology advances are changing the role of tires in fleet operations and how the tire industry is improving the eco-friendliness of its products....

at 05:10
RAB Microfluidics Secures Contract With Global Energy Giant to Develop Autonomous Oil Monitoring System for Shipping Vessels
RAB Microfluidics has secured a £750,000 contract with a global energy giant to develop an autonomous oil monitoring system for 2-stroke marine vessel engines, based on its patented ?lab-on-a-chip' technology. Upon completion, RAB's autonomous oil...

at 05:05
Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...

at 05:05
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...

at 05:05
UKG: April Shift Work Growth Slows. What Does It Mean?
UKG: Summary: April shift work squeaked by with another monthly gain, as workforce activity increased 0.2%, according to the April 2024 Workforce Activity Report published by UKG. Although April marked the third consecutive month of gains in...

at 05:00
New Independent Study Shows 70% of Organizations Prioritize Gen AI for Boosting Employee Productivity
Apexon, a digital-first technology services company, today unveiled key findings from a Forrester Opportunity Snapshot Study "Regulated Industries Are Making Generative AI Core to Their Digital Strategy." The study...

More news about Science and technology...


News published on and distributed by: